Dr. Mario Suva is an Associate Professor of Pathology at Harvard Medical School and Massachusetts General Hospital, is affiliated with the Neuro-Oncology program at Dana-Farber/Harvard Cancer Center, and is a member of the Broad Institute of MIT and Harvard. Dr. Suva's lab focuses on the biology of brain tumors, using single-cell technologies to dissect cellular heterogeneity and plasticity. Furthermore, recent work from his lab describes an atlas of glioma-infiltrating T cells, which we discuss in this episode. For more information, visit his lab page: Suva Lab

Scientist the Human Podcast

STH - E27 Dr. Mario Suva

Dr. Mariella G. Filbin is an Attending Physician of Pediatric Oncology at Dana-Farber Cancer Institute, an Assistant Professor of Pediatrics at Harvard Medical School, and an Associate Member of the Broad Institute of Harvard and MIT. The Filbin Lab focuses its efforts on studying pediatric brain tumors, particularly lethal high-grade gliomas, including diffuse intrinsic pontine glioma (DIPG) and malignant embryonal brain tumors. Dr. Filbin's approach to understanding these tumors involves genomic technologies such as single cell RNA sequencing, which we discuss in this episode. For more information, visit her lab page: Filbin Lab

STH - E26 Dr. Mariella G. Filbin

Laura Valente is a PhD student in the Department of Pathology at Duke University School of Medicine. She conducts research in the lab of Dr. Anthony Filiano, who is a faculty member in the Neurosurgery, Immunology, and Pathology departments at Duke. Laura's work focuses on developing mouse models of thymus transplants done in patients to understand the underlying mechanisms of thymus transplant efficacy. Recently, Laura took part in a science advocacy workshop called Catalyzing Advocacy in Science and Engineering (CASE), held by the American Association for the Advancement of Science (AAAS). In this episode, we discuss Laura's research and her recent crash course in science advocacy. For more information on Laura's research, please visit the Filiano Lab website. For more information on the CASE workshop, please visit the AAAS CASE website. 

STH - E25 Laura Valente

Dr. Kris Wood is an Assistant Professor in the Department of Pharmacology and Cancer Biology and the Department of Biomedical Engineering at Duke University. The Wood Lab utilizes functional genomics approaches to uncover targetable vulnerabilities in different types of human cancers. Much of this work is driven by investigation of the complex signaling networks that drive tumor formation and progression. Dr. Wood's research also leads to identification of combinatorial treatment strategies for cancers that evolve to develop resistance to monotherapies. For more information visit his lab page: Wood Lab 

STH - E24 Dr. Kris Wood

Dr. Herman Staats is a Professor and the Vice Chair for Research in the Department of Pathology at Duke University School of Medicine. Broadly, the Staats Lab focuses on vaccines and immunity. The lab's main projects include identifying and characterizing new adjuvants, and optimizing nasal immunization for use in humans. An adjuvant is any substance co-administered with a vaccine to enhance the immune response to the vaccine, and we discuss this topic in detail in this episode. For more information visit his lab page: Staats Lab   

STH - E23 Dr. Herman Staats

Katie Stember is a PhD candidate in the lab of Dr. Ronald Falk at the University of North Carolina (UNC) School of Medicine. Broadly speaking, Katie works on a family of autoimmune diseases called antineutrophil cytoplasmic autoantibody (ANCA) vasculitis, which affects blood vessels throughout the body. Her research focuses on the interaction between autoreactive T cells and known self-antigens in this disease, which we discuss in detail in this episode. In addition to being a biomedical researcher, Katie is the founder and curator of Scientists of North Carolina, a Facebook page dedicated to bringing the public closer to scientists and their stories. 

STH - E22 Katie Stember

Eric Wang is a PhD candidate in the lab of Dr. Iannis Aifantis at the NYU School of Medicine. Broadly speaking, Eric's research focuses on transcriptional regulation during leukemia initiation. To this end, he recently conducted a pooled CRISPR screen on about 500 target genes, from which a gene involved in RNA splicing emerged as a top candidate as being required for leukemia cells to live. In addition to this screen, we discuss Eric's unique path to his current position and his recent PhD qualifying exam. For more information on Eric's and Dr. Aifantis' research, visit his lab page: Aifantis Lab 

STH - E21 Eric Wang

Dr. Aristotelis Tsirigos is an Associate Professor of Pathology and the Director of the Applied Bioinformatics Center at the NYU School of Medicine, where his group uses computational methods to study biology. In particular, his work has centered around using computer science to elucidate epigenetic alterations in T-cell acute lymphoblastic leukemia, also known as T-ALL. Prior to joining NYU as a faculty member, Dr. Tsirigos worked as a Research Scientist at IBM, which we discuss in this episode. For more information visit his lab page: Tsirigos Lab 

STH - E20 Dr. Aristotelis Tsirigos

Dr. Yiping He is an Assistant Professor of Pathology at Duke University, where his lab focuses on exploiting genetic alterations for cancer treatments, particularly for glioblastoma (GBM), a type of brain tumor. Another area of focus in the He Lab is medulloblastoma, which is a type of malignant pediatric brain tumor located in the cerebellum, the lower-rear area of the brain. One of the ways Dr. He conducts this research is using patient-derived tumor tissue, which we discuss in this episode. For more information visit his web page: He Lab 

STH - E19 Dr. Yiping He

Dr. Bryan Field is an Assistant Professor of Physics at SUNY Farmingdale on Long Island, New York. He is a theoretical particle physicist, and his work focuses on understanding results from the Large Hadron Collider (LHC) at CERN and in the past he has actively collaborated on experiments involving ATLAS, which is one of two general-purpose detectors at the LHC. In particular, Dr. Fields is interested in the properties of the recently discovered Higgs Boson in the Standard Model of particle physics, as well as a concept known as supersymmetry, which is discussed at length in this episode. For more information visit his web page: Dr. Bryan Field 

STH - E18 Dr. Bryan Field

Dr. Vanja Sisirak is a Research Associate in the department of Pathology at the NYU School of Medicine. He is a member of the Reizis Lab, where he studies the pathogenesis of systemic lupus erythematosus, an autoimmune disease in which the the body's immune system attacks "self" rather than foreign pathogens. Although lupus is difficult to diagnose, an interesting marker of this disease is the presence of antibodies against one's own double-stranded DNA, which is among the topics discussed in this episode. For more information, visit the Reizis Lab web page. 

STH - E17 Dr. Vanja Sisirak

Dr. Sarah LeBoeuf is a postdoctoral researcher in the department of Pathology at the NYU School of Medicine. She is a member of the Papagiannakopoulos Lab, where she uses genetically engineered mouse models to study the role of mitochondria and reactive oxygen species stress in the development and progression of lung cancer. Among the goals of Dr. LeBoeuf's research is to elucidate the metabolic rewiring of cancer cells of specific genetic backgrounds so that they can be targeted therapeutically with small molecule drugs. For more information, visit the Papagiannakopoulos Lab web page. 

STH - E16 Dr. Sarah LeBoeuf

Joey Verdi is a PhD candidate in the lab of Dr. Jayne Raper at CUNY-Hunter College, where he is conducting research on the apolipoprotein L-1 (apoL1) gene and its variants across multiple species of primates and monkeys. The apoL1 protein produced by this gene is a part of a larger complex of proteins termed trypanosome lytic factors (TLFs), which contribute to the innate immunity of primates against African trypanosomes, a flagellated parasite. Joey's work lends itself to the Transgenic Cattle Project and in this episode we discuss his involvement in this endeavor. 

STH - E15 Joey Verdi

Dr. Andrew Hill is a cognitive neuroscientist and lecturer at UCLA. He conducts research on attention and cognitive performance, and he is the Lead Neuroscientist for truBrain, a start-up that offers nootropic supplements, in the form of capsules and drinks (nootropics are drugs that may enhance memory and focus, however much of the research elucidating mechanisms of action of these drugs remains to be done). Dr. Hill is also a cofounder of Alternatives Addiction Treatment, a start-up that offers addiction treatment on the basis of biofeedback, discussed in this episode. For more information, visit the websites of truBrain and Alternatives Addiction Treatment. 

STH - E14 Dr. Andrew Hill

Dr. Ernest Davis is a professor of computer science at the Courant Institute of Mathematical Sciences at New York University. He is an expert on artificial intelligence - he studies the problem of representing commonsense knowledge (basic knowledge about the real world that is common to all humans) and expressing it in a form that is systematic enough to be used by a computer program. Dr. Davis' research includes topics such as the problem of reasoning about containers and the ontology of matter, both of which are discussed in this episode. We also go into detail about potential applications and whether or not artifical intelligence poses a threat. Visit his website for more information here. 

STH - E13 Dr. Ernest Davis

A laid-back conversation with research scientists engaged in exciting work. Will we discuss their research? Of course! But we will also attempt to explore the path these individuals took in getting to where they are today. My goal is to get to know the human behind the scientist. Join in!

hubhopper

Scientist the Human Podcast

hubhopper